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Correspondence
Letter by Carapetis Regarding Article, “Is
Primary Prevention of Rheumatic Fever the
Missing Link in the Control of Rheumatic Heart
Disease in Africa?”
To the Editor:
Karthikeyan and Mayosi make a compelling case for increasing
the focus on sore throat treatment in Africa with the aim of
preventing rheumatic fever.1 However, in citing one of my articles in
relation to their statement “Several arguments have been made
against adopting primary antibiotic prophylaxis for the prevention of
RF and RHD as a public health intervention in the community,” I
believe they have misrepresented my position. I have never argued
against the importance of treating streptococcal sore throat in
primary care. On the contrary, I have repeatedly reinforced the
importance of this strategy in review articles and book chapters.
However, such an approach, in itself, is not proven to reduce the
incidence of rheumatic fever, and I have also argued that systematic
school- or community-based programs of swabbing sore throats and
administering antibiotics to those with positive cultures for group A
streptococci are not cost effective, particularly for developing coun-
tries. A recent meta-analysis of studies of such interventions in-
cluded only one randomized controlled trial alongside two observa-
tional and three before-and-after studies.2 I believe that the data from
the latter five studies were not of sufficient quality to warrant their
inclusion in a meta-analysis. The randomized controlled trial in-
cluded almost 87 000 person-years of observation, and the authors
did not observe a significant reduction in rheumatic fever incidence.
In my opinion, Karthikeyan and Mayosi are also incorrect in
saying that the Cuban and Costa Rican experiences present “incon-
trovertible evidence that primary prevention really works.” These
were ecological studies, which do not allow attribution of causation
to a particular intervention. In Costa Rica, the reduction of rheumatic
fever incidence occurred over many years and coincided with many
other factors (eg, the introduction of a national health care plan) that
could have contributed to a reduction in rheumatic fever incidence.3
In Cuba, the reduction in rheumatic fever incidence coincided with
the introduction of a comprehensive control program that included
primary prophylaxis and also “secondary prevention of ARF/RHD,
training of health personnel, healthcare education via dissemination
of information, community involvement and epidemiological sur-
veillance.”4 These reports support the use of a sore throat treatment
strategy as an important component of a multifaceted strategy that
includes primary prophylaxis as one important component.
I support the view of Karthikeyan and Mayosi that primary
prophylaxis in developing countries should be based in primary
health care and cannot rely on the availability of microbiological
diagnosis. The available evidence suggests that the most successful
approaches include this as one element of a comprehensive package
such as was instituted in Cuba and previously in the French
Caribbean,5 the most important benefit of which may be increased
awareness of rheumatic fever, its prevention, and its management by
health staff and in the general population. This is the strategy we
should be advocating, and we should avoid making specific claims
about the likely effectiveness at the population level of primary
prophylaxis alone, when this is not supported by the available
evidence.
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